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Introduction
Neglected tropical diseases (NTDs) cause
significant morbidity and mortality world-
wide and impose a large economic burden
on endemic countries [1]. In 2006, the
United States Agency for International
Development (USAID) founded the NTD
Control Program to target five NTDs in
African, Asian, and Latin American coun-
tries, namely, lymphatic filariasis (LF), on-
chocerciasis, schistosomiasis, soil-transmitted
helminthiases (STH), and trachoma; the
three targeted STH infections are asca-
riasis, hookworm, and trichuriasis. The
NTD Control Program supported na-
tional NTD control and elimination
programs’ efforts to integrate and scale
up delivery of preventive chemotherapy
(PC) [2]. PC is the administration of
safe, single-dose drugs, either alone or in
combination, as a public health interven-
tion against targeted NTDs. Administra-
tion is characterized by population-based
diagnosis, population-based treatment,and
implementation at regular intervals. PC
can be delivered as universal chemother-
apy (i.e., mass drug administration
[MDA]), where the entire population of
an area is targeted; targeted chemother-
apy, where only high-risk groups (e.g.,
school age children) are targeted; or
selective chemotherapy, where only
screened individuals found or suspected
to be infected are targeted [3]. Between
October 2006 and March 2012, the
program provided 589 million NTD treat-
ments through the collaborative efforts of
ministries of health, implementing partners,
funders, and pharmaceutical donation
programs.
The implementation of integrated NTD
programs at the full national scale remains
an important objective in many endemic
countries [4–8]. Several theoretical frame-
works for integration have been proposed;
most protocols stress the importance of
long-term commitments and concerted
efforts of partnerships to realize NTD
control and elimination objectives [9–14].
However, there is currently a paucity of
economic evidence on the costs of inte-
grated PC delivery for NTDs, primarily
due to the significant variation in program
structures and operations [14]. Given the
scarce resources and substantial costs asso-
ciated with NTD control and elimination,
there is therefore a need to accurately
determine the cost of program implemen-
tation. It is also important to delineate
funding commitments to ensure that
additional assistance is used to comple-
ment available resources, rather than
duplicate or replace previous efforts.
To allow governments to more easily
enumerate costs and funding commit-
ments for NTD control and elimination,
the NTD Control Program developed the
Tool for Integrated Planning and Costing
(TIPAC). The TIPAC, a versatile plan-
ning and costing instrument, is designed
to be used by members of a NTD pro-
gram at the national level. For countries
with decentralized political structures, the
TIPAC can also be implemented at a
subnational administrative level. NTD
program and financial managers are the
primary users of the tool; the involvement
of other personnel, including representa-
tives from partner organizations and
ministries of education, improves the
accuracy and completeness of the TIPAC
data.
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The TIPAC implementation process
includes four main phases:
1. Background data collection: country
coordinators compile, review, and
verify demographic, epidemiologic,
and cost classification data. In coun-
tries where individual disease control
programs are not integrated, this phase
may generate fruitful discussions among
stakeholders and stimulate collabora-
tion on program planning, outreach,
implementation, and monitoring.
2. Data entry: a focal person appointed
by the national program enters the
planned activity costs. The national
strategic plans for NTD control and
elimination, also referred to as master
plans, serve as the guiding documents
for data entry. As the tool is populated,
integration opportunities and areas of
overlap and duplication are identified.
After the costs are entered, stakeholder
meetings are convened to identify drug
and funding commitments.
3. Finalization and approval: the entered
data is reviewed by all stakeholders and
approved for use by ministry of health
representatives from the national NTD
control and elimination program.
4. Results application: the results can be
used to inform and guide annual work
plans, drug applications, donor coordi-
nation efforts, and advocacy and fun-
draising strategies. The TIPAC is able
to convert the information in the tool
for use during another funding year,
thereby facilitating data entry in sub-
sequent years.
The aim of this feasibility study is to
assess whether the TIPAC effectively in-
forms and facilitates country program
decision-making and the integration of
program activities. This study presents
excerpts from data collected in two
African countries (Sierra Leone, fiscal year
[FY] Oct. 2010–Sept. 2011, and Tanza-
nia, FY Oct. 2010–Sept. 2011), one Asian
country (Nepal, FY Jul. 2010–Jul. 2011),
and one Latin American country (Haiti,
FY Oct. 2011–Sept. 2012). The lessons
learned from implementing the TIPAC in
these four countries can guide the plan-
ning and costing of annual NTD control
and elimination activities in other NTD-
endemic countries.
Methods
The TIPAC structure
The initial 2009 tool was a one-page
spreadsheet in Microsoft Excel which
allowed users to enter cost and funding
levels for planned NTD program activities.
A subsequent multisheet Excel workbook
was developed, which enabled users to
more accurately specify activity costs (i.e.,
list the component costs of individual
activities). In 2009 and 2010, the tool
was implemented in 14 countries (Burkina
Faso, Cameroon, Ghana, Haiti, Nepal,
Niger, the Philippines, Senegal, Sierra
Leone, South Sudan, Tanzania, Togo,
Uganda, and Vietnam) by technical ad-
visers in collaboration with ministries of
health. Based on these experiences, it was
revised in 2012 to strengthen its function-
ality and user-friendliness, increase the
transparency of cost inputs, and enable
more advanced customizable reports. Pri-
or to 2012, the tool was known as the
Funding Gap Analysis Tool (FGAT). The
newest version of the tool, available in
Bahasa Indonesia, English, French, Portu-
guese, and Spanish, facilitates program
planning and budgeting. The main im-
provements include a timeline of activities,
an expanded capacity to enter information
for non-PC NTDs, and a five-year projec-
tion of activity costs and PC drug needs.
The current TIPAC version was devel-
oped in Microsoft Excel 2007. The tool
applies an iterative approach to guide
users through data entry, with user forms
designed in Visual Basic for Applications
(VBA). It includes four data entry modules
and one reports module:
1. Base data: stores demographic, epide-
miologic, and program information for
use throughout the tool.
2. Activity costs: collects costs of NTD
program activities.
3. PC drug acquisition: estimates PC drug
demand and costs (see Text S1 for the
PC target population and drug de-
mand algorithms).
4. Funders: saves information about gov-
ernment and donor budgets.
5. Reports: synthesizes results and facili-
tates data analysis; the tool automati-
cally generates summary analyses (i.e.,
figures and tables).
The planning and costing of activities
are based on World Health Organization
(WHO) treatment guidelines for imple-
menting integrated PC disease control
programs and the scope of the national
strategic plans [15–19]. Table S1 summa-
rizes the default activities and sub-activities
captured by the tool; users are also able
to add other activities and sub-activities.
Assessment of feasibility
This paper examines the feasibility of
the TIPAC to support country program
decision making and the integration of
program activities. Feasibility is assessed
based on the five tool objectives:
1. Estimate the costs of implementing
integrated NTD programs in accor-
dance with international guidelines and
national plans of action.
2. Quantify the existing resources of
governments and donors.
3. Identify the funding gaps of the
national NTD programs.
4. Encourage the rational allocation of
resources and coordination between
governments, implementing partners,
and donors.
5. Facilitate the identification of integra-
tion opportunities and annual planning
of NTD programs.
The countries represented in this study
(Haiti, Nepal, Sierra Leone, and Tanza-
nia) were selected to provide a diverse
geographic distribution and varied disease
landscapes for analysis. Of the four,
Tanzania is the only country treating all
five diseases, while Haiti, Nepal, and
Sierra Leone treat two, three, and four
diseases, respectively. Haiti and Sierra
Leone targeted 100% of the endemic
districts for treatment. Nepal targeted all
districts for STH treatment, but is con-
tinuing to scale up treatment for LF and
trachoma. Tanzania only provided data
for 25 districts that were targeted with
USAID funding, or 19% of the total
number of districts. An additional 36
districts in Tanzania were supported by
the African Programme for Onchocercia-
sis Control (APOC), but were not included
in the TIPAC. Tanzania is using a phased
approach to scale up NTD treatment and
has not yet reached 100% geographic
coverage. Key information on the national
NTD programs is summarized in Table 1.
All monetary values entered into the
TIPAC were converted to US dollars ($)
using the exchange rate provided by a
government employee or technical adviser
at the time of data entry (i.e., $1 was
equivalent to HTG 40.0 [Haiti], NRS
75.7 [Nepal], SLL 3,920.0 [Sierra Leone],
and TZS 1,550.0 [Tanzania]). All the data
were initially entered into an earlier
version of the TIPAC and later transferred
to an updated version. The cost and
funding data were obtained from the
perspective of national NTD programs.
Results
The level of time and effort required for
data entry varied across the four countries
depending on the size, scope, complexity,
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and maturity of the programs. In most
cases, ten working days were needed to
enter the vast majority of the data;
additional input and refinement was
possible as new information became avail-
able. Each country program received in-
country assistance from a trained facilita-
tor who introduced the TIPAC to pro-
gram managers and provided technical
support during implementation. Programs
were encouraged to appoint a national
focal person to maintain and update the
TIPAC for subsequent work planning. In
all four countries, data were successfully
generated that contributed to the following
key objectives.
Objective 1: Estimate the costs of
implementing integrated NTD
programs in accordance with
international guidelines and national
plans of action
The epidemiological data captured in
the Base Data module were used by
countries to set targets and estimate
annual costs to operationalize national
plans of action. Table 2 summarizes the
target age group, target population, and
number of districts targeted for each
disease in Sierra Leone. All four countries
inputted program costs for PC and non-
PC activities and complementary NTD
control strategies (e.g., vector control).
Both economic and financial costs were
generated by the tool; financial costs
excluded the monetary value of donated
drugs (i.e., only cash disbursements were
considered). Table 3 lists Haitian activity
costs captured in the tool, excluding
salaries and drug costs. Reports generated
by the TIPAC also showed the cost
distribution by sub-activity or line item.
In addition, countries were able to
calculate the average projected cost per
person for PC NTDs. Table 4 details the
estimated aggregate and per-person eco-
nomic costs in Haiti. These included
implementation and operational costs, as
well as the costs of donated and purchased
drugs; salaries were excluded from these
estimates. The NTD program managers
were then able to determine the relative
cost differences between diseases, which
allowed for more informed planning and
opportunities to reduce costs in subsequent
years.
Objective 2: Quantify the existing
resources of governments and
donors
To illustrate the ability to quantify
existing resources from government and
donor budgets (e.g., bilateral donors and
nongovernmental organizations [NGOs]),
Table 5 shows the overall funding by
activity and funding source in Nepal; the
table includes salaries, but excludes drug
costs and donations. All funds in Nepal
were assigned to specific activities, sub-
activities, and districts, to match the
funder’s intent. The TIPAC results reflect-
ed the government of Nepal’s funding
commitment, as well as the allocation of
resources through a pooled fund. While
the money included in the pooled fund
was provided by external donors, the
government of Nepal decided how to
allocate the money. The government
funding and the pooled fund accounted
for over 70% of the total funding.
In Sierra Leone, staff salaries contrib-
uted to 15% of the total program funding,
while government resources allocated
through the national budgeting process
accounted for less than 1% of the total.
This data helped the Ministry of Health
and Sanitation (MOHS) better understand
the annual costs of implementing NTD
activities, the financial commitments of
donors, and the resources required for
scaling up to reach national coverage. It
motivated the MOHS to increase their
financial commitment for drug distribu-
tion, drug storage, and personnel salaries.
Objective 3: Identify the funding
gaps of the national NTD programs
The TIPAC provided program manag-
ers with a valuable advocacy tool and an
opportunity to communicate to funders
how available resources aligned with
planned activities and where additional
assistance was needed. For example, in the
four countries described in this study, the
results of the TIPAC were used during
annual planning to identify funding gaps
and to guide the budget requests for
USAID support. Notably, the implemen-
tation of the TIPAC in Sierra Leone
reaffirmed that morbidity control and
surgery (i.e., hydrocele surgery and lymph-
edema management) was underfunded.
Johnson & Johnson therefore recommitted
funding for hydrocele surgeries and phy-
sician training on novel hydrocele surgery
techniques. Thus far, more than 150
patients have received free operations
and 50 physicians have obtained supple-
mentary training. In Nepal, the data entry
process enabled the program to identify
and quantify the funding gap, which
corresponded to 10.3% (515,082/5,011,
643) of the total budgeted program costs.
Potential gaps in the quantity of drug
units required for each targeted PC NTD
and the associated costs were automatical-
ly calculated for each country based on
their respective epidemiologic statuses and
the entered program goals for the time
period (i.e., population and number of
districts targeted for treatment). This
information was used to check against
drug procurement records to confirm
whether quantities of donated and pro-
cured drugs were sufficient to cover
targeted districts. Table 6 summarizes
the drug acquisition data from Tanzania.
Objective 4: Encourage the rational
allocation of resources and
coordination between governments,
implementing partners, and donors
In Haiti, populating the TIPAC allowed
the various partners, including depart-
ments within the Ministry of Public Health
and Population (MSPP), to share informa-
tion on the NTD activities they were
conducting or planning. These activities
included morbidity management, vector
control through the use of long-lasting
Table 1. Overview of NTD control programs.*
Country LF Oncho SCH STH Trachoma Total population
# of people
targeted
Total # of
districts
# of districts
targeted
Haiti 3 3 9,897,749 9,254,397 140 140
Nepal 3 3 3 28,076,055 17,151,069 75 75
Sierra Leone 3 3 3 3 5,890,280 5,005,105 14 14
Tanzania 3 3 3 3 3 41,422,687 7,504,657 130 25
* The demographic and district figures from Table 1 represent country situations at the time of data entry.
doi:10.1371/journal.pntd.0002619.t001
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insecticide treated nets (LLITNs), and a
new proposal to implement a second
round of mebendazole for STH in target-
ed districts. Although the second round of
mebendazole was not approved by the
MSPP, further discussions led the Inter-
American Development Bank (IDB)
to instead finance a second round of
albendazole in five districts. Through this
process, the MSPP gained an enhanced
understanding of the contributions of
its partners and adjusted implementation
strategies when appropriate.
Table 7 provides a summary of the
work plan matrix and timeline in Haiti
generated for the period of October 2011
to September 2012. Based on the user’s
selection of targeted months and years, the
matrix provided a one-year overview of
Haiti’s activities and subactivities. This
output was used by program managers to
coordinate among partners and identify
any spatial and temporal overlap.
Objective 5: Facilitate the
identification of integration
opportunities and annual planning
of NTD programs
Given that the desired number of PC
treatments administered is fixed, program
managers were able to determine the costs
of alternative PC approaches (e.g., stand-
alone or integrated NTD activities in co-
endemic regions) and revise policies ac-
cording to specific cost drivers. The
implementation of the TIPAC in Nepal,
alongside other strategic planning discus-
sions, highlighted potential integration
opportunities across the LF, STH, and
trachoma programs. For example, the
national NTD program in Nepal is now
integrating information, education, and
communication (IEC) materials for the
three diseases. The program also consid-
ered integrating training procedures.
However, due to the disease-specific
training strategies and reports of serious
adverse effects (SAEs) from previous LF
PC rounds, the national program decided
not to integrate training. Nepal’s experi-
ence highlights the usefulness of the
TIPAC for identifying integration oppor-
tunities, and it emphasizes the need to
make country-specific decisions on which
activities are feasible and appropriate to
integrate.
Discussion
Health systems worldwide operate un-
der relentless fiscal pressure to curb
escalating costs. The emphasis on cost
containment is heightened in low- and
middle-income countries where scarce
resources necessitate improved resource
allocation for NTD programs. Previous
studies calculating the costs of implement-
ing NTD activities have mostly consisted
of retrospective analyses of PC costs [20–
22]. The data have usually been collected
from interviews or financial expenditure
records and entered into spreadsheets or
databases. Before the TIPAC was devel-
oped, the WHO Regional Office for
Africa (AFRO) introduced a tool to
support African countries in defining
comprehensive budget plans in accor-
dance with their NTD master plans. The
tool allowed users to approximate the
costs of a multiyear NTD program using
activity-based costing and served as a
precursor to the TIPAC in under-
standing how national programs apply a
comprehensive multiyear financing tool
[23]. This knowledge, combined with the
recognition of the need for an annual
work-planning tool to produce an accurate
and detailed estimate of funding and drug
requirements, guided the development of
the TIPAC. The main advantages and
limitations of the TIPAC and the tool
implementation process are presented in
Box 1.
Generating accurate cost estimates
The ability to itemize activity costs in
the TIPAC-enabled countries to generate
detailed estimates of annual program
costs. These cost estimates were used to
Table 2. Sierra Leone base data (FY Oct. 2010–Sept. 2011).
Disease Target age group for PC Target population for PC Number of districts targeted for PC
LF $5 years 4,888,932 14
Oncho (Round 1) $5 years 2,403,894 12
Oncho (Round 2) $5 years 0 0
SCH School age 485,739 7
High-risk adults 1,303,644 7
STH (Round 1) Preschool age 0 0
School age 1,590,376 14
High-risk adults 3,298,556 14
STH (Round 2) School age 485,739 7
Trachoma ,6 months 0 0
6–59 months 0 0
$5 years 0 0
doi:10.1371/journal.pntd.0002619.t002
Table 3. Haiti activity costs (in $, FY
Oct. 2011–Sept. 2012).
Activity Total cost Percent
Implementation costs
PC drug distribution 1,255,079 45.1%
Social mobilization 755,125 27.1%
PC training 473,902 17.0%
Medication for side
effects
145,913 5.2%
Monitoring and
evaluation
56,799 2.0%
PC preparation 46,270 1.7%
Strategic planning 14,965 0.5%
Drug logistics 14,590 0.5%
Department supervision 8,759 0.3%
Operational costs
Office equipment 14,075 0.5%
Total program costs 2,785,477 100.0%
doi:10.1371/journal.pntd.0002619.t003
PLOS Neglected Tropical Diseases | www.plosntds.org 4 February 2014 | Volume 8 | Issue 2 | e2619
inform funding requests and were helpful
for countries when discussing funding
strategies with stakeholders. However, like
other costing tools, the TIPAC allows for
some inter-user variability; the quality of
the results depends on the accuracy and
integrity of the inputs. As previously noted,
Tanzania only provided data for 25
districts that were targeted with USAID
funding, which suggests a narrow applica-
tion of the TIPAC to plan and cost NTD
control and elimination activities. The
inclusion or exclusion of activities on the
basis of the funding source biases results
and represents a salient challenge when
coordinating activities across multiple
implementing organizations.
It is also important to remember that
the costs entered into the TIPAC reflect
planned expenditures and not necessarily
realized expenditures. In some cases,
reliance on the tool may therefore estab-
lish expectations for funding. This may
impact the validity of data if a user believes
that entering a cost will increase the
likelihood of future funding. To minimize
the inflation of the budgeted costs, it is
suggested that programs start planning
based on program strategies from previous
years and involve the national personnel
responsible for finances. Additionally, a
well-trained point person in the MOH
who is in charge of managing the imple-
mentation process can help to set realistic
goals and cost thresholds. In Nepal, data
were entered by representatives with
complementary technical, programmatic,
and financial expertise. Overall, a partic-
ipatory data entry process that involves
multiple stakeholders improves the trans-
parency and quality of the TIPAC results.
Calculating funding commitments
and gaps
The results of the TIPAC highlighted
the commitments made by governments
and implementing partners. In particular,
the TIPAC’s automated calculation of
government salaries outlined national own-
ership of NTD programs. Countries with
limited resources may not be able to
allocate substantial funds through their
national budgeting process, but can show
their commitment through the employ-
ment of full- and part-time employees for
NTD control and elimination. Goldman
and colleagues noted the importance of
capturing government choices of resource
allocation but faced challenges estimating
the proportion of staff time spent on LF-
specific efforts [21]. By allocating the
entire salaries of full-time staff to pro-
gram costs and apportioning the salaries
of part-time staff based on the number of
event and travel days entered, countries
that used the TIPAC eliminated recall
bias that may arise when government
employees are asked to track their time
spent on NTD activities.
Inter-country differences in cost alloca-
tions were expected due to variations in
population sizes, disease burdens, relative
purchasing power parities, levels of inte-
gration of sub-activities, and year-to-year
fluctuations in program foci (e.g., changes
in mapping needs and treatment histories).
This study did not analyze differences in
Table 4. Haiti economic cost per person targeted (in $, FY Oct. 2011–Sept. 2012).
LF Oncho SCH STH Trachoma All PC
Total program costs 1,958,292 0 0 1,533,513 0 3,491,805
Number of persons targeted 9,254,397 0 0 2,474,438 0 9,254,397
Cost per person targeted 0.21 0.00 0.00 0.62 0.00 0.38
Number of districts targeted 140 0 0 140 0 140
doi:10.1371/journal.pntd.0002619.t004
Table 5. Nepal funders, by activity (in $, FY Jul. 2010–Jul. 2011).*
Activity Cost Funding Gap Government Pool fund USAID CNTD/LSTM
Embassy of
India
Lions
Club
Int’l
Implementation costs
Salaries 986,036 986,036 0 986,036 0 0 0 0 0
Drug logistics 190,372 183,340 7,031 151,192 25,007 7,142 0 0 0
Mapping 28,503 28,503 0 0 0 28,503 0 0 0
PC drug distribution 956,597 934,453 22,145 466,076 324,347 144,029 0 0 0
PC registration 554,030 483,425 70,605 0 0 483,425 0 0 0
PC training 1,308,672 973,329 335,344 68,854 738,171 166,304 0 0 0
Monitoring and evaluation 180,139 151,158 28,981 4,262 59,670 53,293 22,655 0 0
Morbidity control and surgery 137,446 121,181 16,265 0 2,642 3,196 0 29,062 85,687
Social mobilization 492,435 481,316 11,118 230,334 119,551 92,871 38,560 0 0
Strategic planning 139,706 116,113 23,594 89,053 0 16,227 10,834 0 0
Operational costs
Running costs 37,707 37,707 0 20,876 0 16,831 0 0 0
Total program costs 5,011,643 4,496,561 515,082 2,016,682 1,269,388 1,011,821 72,049 29,062 85,687
* CNTD=Centre for Neglected Tropical Diseases; LSTM= Liverpool School of Tropical Medicine; USAID =United States Agency for International Development.
doi:10.1371/journal.pntd.0002619.t005
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costs across countries. As costs were
entered in current dollars for a given year,
comparisons over time and across coun-
tries regarding funding commitments and
achievement towards closing gaps would
need to be converted to a base year. It
would be useful, however, to monitor the
progress of programs towards narrowing
funding gaps over time. Levels of funding
support are expected to change as donors
re-evaluate funding commitments and
strive to eliminate funding gaps.
Improving coordination
For nationally-owned programs, it is
important that ministries of health have a
comprehensive overview of the activities
that are implemented and the funding that
is allocated to NTD control and elimina-
Table 6. Tanzania drug acquisition (in drug units,* FY Oct. 2010–Sept. 2011).**
Drug Manufacturer Donor/funder Total needed Total stock Total funded Gap
IVM tabs Merck Merck & Co. 17,905,801 0 17,905,801 0
ALB tabs (with IVM) GSK/other GSK 7,034,422 0 7,034,422 0
PZQ tabs Multiple USAID 3,179,394 0 1,041,063 2,138,331
TEO tubes Multiple 220,817 0 0 220,817
ZMAX POS bottles Pfizer ITI 328,104 0 328,104 0
ZMAX tabs Pfizer ITI 13,331,922 0 13,331,922 0
* The tool also allowed users to display the monetary value of medicines, instead of the drug units.
** ALB = albendazole; GSK =GlaxoSmithKline; ITI = International Trachoma Initiative; IVM= ivermectin; POS = pediatric oral suspension; PZQ=praziquantel;
TEO= tetracycline eye ointment; USAID=United States Agency for International Development; ZMAX= zithromax.
doi:10.1371/journal.pntd.0002619.t006
Table 7. Haiti annual work plan matrix and timeline (FY Oct. 2011–Sept. 2012).*
Timeline for implementation
Activities and Sub-activities Oct 11 Nov 11 Dec 11 Jan 12 Feb 12 Mar 12 Apr 12 May 12 Jun 12 Jul 12 Aug 12 Sep 12
Strategic planning
National stakeholders meeting x x
Monitoring and evaluation
LF sentinel/spot check site survey x
Drug logistics
Drug importation x x
Drug transportation x x x x
Drug storage x x x x x x
Social mobilization
Development of IEC materials x x
Dissemination of IEC materials and messages x x x x x x
PC training
Training of trainers x x
Training of supervisors x x x x
Training: CDDs x x x x
Training: promoters x x x x
PC preparation
PC preparation x x x x
PC drug distribution
LF and STH (Northern Departments) x x x
STH only x
LF and STH (Port-au-Prince) x
LF and STH (Southern Departments) x x x
Medication for side-effects
Procurement of SAE drugs x
Department supervision
Supervision x x x x x x
* CDD= community drug distributor; IEC = information, education, and communication; PC = preventive chemotherapy; SAE = serious adverse effects.
doi:10.1371/journal.pntd.0002619.t007
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tion. This is necessary to ensure effective
coordination between stakeholders and ra-
tional allocation of resources. For example,
the Global NGO Deworming Inventory
has noted that although many NGOs
administer deworming treatments, the
national programs and the wider de-
worming community are often unaware
of these efforts [24]. By providing a
structured process for sharing planned
activities and funding commitments as
part of annual work planning, TIPAC
implementation helped to improve coor-
dination of activities among the countries
studied and discouraged the duplication
of tasks. In Haiti, sharing preliminary
results from the TIPAC stimulated addi-
tional partners to contribute information
about their NTD prevention efforts. The
process of sharing activity and cost
information through the tool provided a
mechanism for external partners and the
MSPP to coordinate activities as part of
the national strategic plan for NTDs.
During the implementation of the
TIPAC, it was observed that the process
can be time-consuming. If the involved
personnel are not able to participate
throughout the entire data entry period,
it may decrease the accuracy of the cost
estimates and limit the use of the tool for
coordination. It is therefore recommended
that countries accumulate the relevant
data (e.g., target populations and unit
costs) prior to implementing the TIPAC.
Also, after the first year’s entry, users are
able to populate the tool more quickly as
they become accustomed to the tool and
can use the stored information from
previous years. The NTD control program
members in all four countries expressed
positive experiences collaborating with
colleagues during the data entry process;
this finding may be applicable to any
process or tool that helps organize and
share programmatic, epidemiologic, and
financial data in a transparent way.
Facilitating integration
The integration of program elements
provides an important method to reduce
the transaction and administrative costs
of organizing program activities and
sub-activities. The similarity of the strate-
gic approaches for the five NTDs targeted
through PC delivery and the epidemiolog-
ic overlap among affected populations
generate significant integration opportu-
nities [2]. Greater program efficiencies
are expected as individual disease pro-
grams integrate and reach 100% geo-
graphic coverage. As NTD programs
progress, they are frequently able to
improve coordination and practices, limit
wasteful use of resources, and enable staff
specialisation, among other cost advan-
tages [9]. As previously mentioned, the
TIPAC provided a useful platform for
countries to identify integration opportu-
nities and outline mid- to long-term
program strategies.
While these efficiencies may lead to
some cost savings, a consistent decrease in
costs over time is not always expected for
certain activities. For example, turnover
rates among government staff and volun-
teers will generate a continuous need to
retrain personnel. Programs also experi-
ence diseconomies of scale and scope
when targeting hard-to-reach populations.
In addition, costs may increase towards
the end of a program’s lifespan, when
impact assessments are implemented to
monitor the effectiveness of interventions
and to measure progress towards control
and elimination goals. It is therefore
important to not rely exclusively on
financing estimates based on average costs
that assume that costs will monotonically
decrease over time.
Conclusions
Implementing the TIPAC in these four
countries offered an opportunity to assess
the feasibility of using a versatile costing
instrument to inform and facilitate re-
source planning. In the study countries,
the TIPAC provided results that were
concordant with the objectives of tool use;
the implementation process also helped
identify key lessons to improve future use.
Populating the tool promoted synergistic
efforts between national NTD programs
and partners to estimate costs accurately,
coordinate activities, identify integration
opportunities, and achieve program goals
to control and eliminate targeted diseases.
Although the TIPAC is not a substitute for
the strategic process of developing a
national plan of action, it should strongly
align with this document to improve
resource planning. Once the financial
landscape is evaluated through the TI-
PAC, a program manager can better
decide the rate at which scale-up is
possible, what activities should be post-
poned until funding is available, and the
Box 1. Advantages and Limitations of the TIPAC and the Tool
Implementation Process
Advantages
N Collaborative stakeholder engagement: improves accountability and coordina-
tion; encourages programs to set realistic objectives.
N Comprehensive data collection: tool use promotes the collection of program-
matic, epidemiologic, and financial data; these data can also be used by
countries for other purposes (e.g., national budgeting or research).
N Itemized costing: enhances program transparency, encourages activity integra-
tion, and helps inform funding requests.
N Long-term outlook: multiyear planning improves the accuracy and validity of the
data and facilitates the identification of long-term cost efficiencies.
N Tool versatility: the data entry process is flexible, and most inputs can be
adjusted based on the needs of individual programs, including those targeting
non-PC NTDs; a generalized version of the tool is also available for use by other
programs (e.g., indoor residual spraying for malaria control).
Limitations
N Inter-user variability: the quality of the results depends on the accuracy and
integrity of the inputs; in-country assistance from a trained facilitator is
recommended to introduce the TIPAC to program managers and to provide
technical support during the initial implementation round.
N Prospective planning exercise: may adversely affect the validity of data if a
user believes that entering higher costs will increase funding; it is important to
involve the national personnel responsible for finances and other stakeholders
when estimating costs.
N Time-intensive: ten working days were usually needed to populate the TIPAC;
however, the duration of the data entry process is shortened once users
become accustomed to the tool and are able to use stored information from
previous years.
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quantity of drugs needed to support
program activities.
Since the development of the TIPAC
for national NTD control programs, the
tool has also been modified and general-
ized for wider applicability. It has been
adapted as a platform to cost and plan
malaria control activities (e.g., indoor
residual spraying [IRS]) and HIV pro-
grams. Additionally, a generic version of
the tool is being developed that can be
applied to other health interventions. The
impetus to apply the TIPAC process to
other projects is due to the growing
need for national programs and donors
to demonstrate efficiencies and to collab-
orate when scaling-up activities and fore-
casting future needs.
The TIPAC was recently recognized
by WHO as a recommended planning
and costing tool for national NTD
programs [25]. It can be used on an
annual basis for PC drug applications to
populate the WHO Joint Request for
Selected PC Medicines. Partners are also
working with WHO, WHO-AFRO, and
other regions to introduce capacity
building workshops for the tool. Overall,
the implementation of the TIPAC in
multiple countries provided a unique
opportunity to assess the challenges of
applying a costing instrument for coun-
try programs. The data and lessons
gathered from this experience will help
standardize NTD control and elimina-
tion planning.
Supporting Information
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